Backs Fy23 adjusted EBITDA view of $65M-$75M
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NSTG:
- Biotech Alert: Searches spiking for these stocks today
- Court permits NanoString counterclaim in 10x Genomics, Harvard litigation
- NanoString backs FY23 revenue view $175M-$185M, consensus $179.13M
- NanoString preliminary Q2 revenue $44M, consensus $41.38M
- NanoString assumed with an Overweight at JPMorgan